Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 5, Issue 11, Pages 1311-1330
Publisher
Future Science, LTD
Online
2013-07-17
DOI
10.4155/fmc.13.86
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A macrolactonization approach to the total synthesis of the antimicrobial cyclic depsipeptide LI-F04a and diastereoisomeric analogues
- (2012) James R Cochrane et al. Beilstein Journal of Organic Chemistry
- Chemoenzymatic deacylation of ramoplanin
- (2012) Raffaella Gandolfi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Effects of Cyclic Lipodepsipeptide Structural Modulation on Stability, Antibacterial Activity, and Human Cell Toxicity
- (2012) Nina Bionda et al. ChemMedChem
- Daptomycin: A Review of Properties, Clinical Use, Drug Delivery and Resistance
- (2012) C. Vilhena et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Daptomycin Resistance in Prosthetic Joint Infections
- (2012) Brahman Sivakumar et al. ORTHOPEDICS
- Modulating Activity of Vancomycin and Daptomycin on the Expression of Autolysis Cell-Wall Turnover and Membrane Charge Genes in hVISA and VISA Strains
- (2012) Viviana Cafiso et al. PLoS One
- Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus
- (2012) Anton Y. Peleg et al. PLoS One
- Daptomycin Resistance in Enterococci Is Associated with Distinct Alterations of Cell Membrane Phospholipid Content
- (2012) Nagendra N. Mishra et al. PLoS One
- In VitroCross-Resistance to Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus Isolates
- (2011) Nagendra N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Basis for Daptomycin Resistance in Enterococci
- (2011) Kelli L. Palmer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- VraSR Two-Component Regulatory System Contributes tomprF-Mediated Decreased Susceptibility to Daptomycin inIn Vivo-Selected Clinical Strains of Methicillin-Resistant Staphylococcus aureus
- (2011) Shrenik Mehta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cyclic Lipodepsipeptides in Novel Antimicrobial Drug Discovery
- (2011) Nina Bionda et al. CROATICA CHEMICA ACTA
- Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development
- (2011) Randal Eckert Future Microbiology
- Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
- (2011) Cesar A. Arias et al. NEW ENGLAND JOURNAL OF MEDICINE
- An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus
- (2010) L. Cui et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carotenoid-Related Alteration of Cell Membrane Fluidity ImpactsStaphylococcus aureusSusceptibility to Host Defense Peptides
- (2010) Nagendra N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cell Wall Thickening Is Not a Universal Accompaniment of the Daptomycin Nonsusceptibility Phenotype in Staphylococcus aureus: Evidence for Multiple Resistance Mechanisms
- (2010) S.-J. Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetically Engineered Lipopeptide Antibiotics Related to A54145 and Daptomycin with Improved Properties
- (2010) K. T. Nguyen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of a Genetic System for Combinatorial Biosynthesis of Lipopeptides in Streptomyces fradiae and Heterologous Expression of the A54145 Biosynthesis Gene Cluster
- (2010) D. C. Alexander et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Clostridium difficileinfection: update on emerging antibiotic treatment options and antibiotic resistance
- (2010) Dhara Shah et al. Expert Review of Anti-Infective Therapy
- Generation of ramoplanin-resistant Staphylococcus aureus
- (2010) John W. Schmidt et al. FEMS MICROBIOLOGY LETTERS
- Diversity of Nonribosomal Peptide Synthetases Involved in the Biosynthesis of Lipopeptide Biosurfactants
- (2010) Niran Roongsawang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Production of novel lipopeptide antibiotics related to A54145 by Streptomyces fradiae mutants blocked in biosynthesis of modified amino acids and assignment of lptJ, lptK and lptL gene functions
- (2010) Dylan C Alexander et al. JOURNAL OF ANTIBIOTICS
- Structural characterization of a lipopeptide antibiotic A54145E(Asn3Asp9) produced by a genetically engineered strain of Streptomyces fradiae
- (2010) Jian-Qiao Gu et al. JOURNAL OF ANTIBIOTICS
- Enduracidin Analogues with Altered Halogenation Patterns Produced by Genetically Engineered Strains ofStreptomyces fungicidicus
- (2010) Xihou Yin et al. JOURNAL OF NATURAL PRODUCTS
- Total Synthesis and Assignment of the Side Chain Stereochemistry of LI-F04a: An Antimicrobial Cyclic Depsipeptide
- (2010) James R. Cochrane et al. ORGANIC LETTERS
- Regulation of mprF in Daptomycin-Nonsusceptible Staphylococcus aureus Strains
- (2009) S.-J. Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureus
- (2009) N. N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Working outside the protein-synthesis rules: insights into non-ribosomal peptide synthesis
- (2009) Mohamed A. Marahiel JOURNAL OF PEPTIDE SCIENCE
- A crystal structure of a dimer of the antibiotic ramoplanin illustrates membrane positioning and a potential Lipid II docking interface
- (2009) J. B. Hamburger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion
- (2009) Christoph M. Ernst et al. PLoS Pathogens
- Serial Daptomycin Selection Generates Daptomycin-Nonsusceptible Staphylococcus aureus Strains with a Heterogeneous Vancomycin-Intermediate Phenotype
- (2008) I. L. B. d. C. Camargo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community‐Acquired Pneumonia
- (2008) Peter E. Pertel et al. CLINICAL INFECTIOUS DISEASES
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Biosynthesis and Genetic Engineering of Lipopeptide Antibiotics Related to Daptomycin
- (2008) Richard Baltz CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus
- (2008) J. K. Hobbs et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate
- (2008) M. H. Murthy et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Identification and functional analysis of the fusaricidin biosynthetic gene of Paenibacillus polymyxa E681
- (2007) Soo-Keun Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
- (2007) B. Spellberg et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now